Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Net Margin (2016 - 2025)

Historic Net Margin for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to 492.45%.

  • Ocular Therapeutix's Net Margin fell 2055300.0% to 492.45% in Q4 2025 from the same period last year, while for Dec 2025 it was 507.2%, marking a year-over-year decrease of 2481500.0%. This contributed to the annual value of 507.2% for FY2025, which is 2481500.0% down from last year.
  • Latest data reveals that Ocular Therapeutix reported Net Margin of 492.45% as of Q4 2025, which was down 2055300.0% from 467.35% recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Net Margin registered a high of 142.09% during Q3 2023, and its lowest value of 589.6% during Q1 2025.
  • Over the past 5 years, Ocular Therapeutix's median Net Margin value was 189.7% (recorded in 2021), while the average stood at 259.05%.
  • Per our database at Business Quant, Ocular Therapeutix's Net Margin skyrocketed by 10600100bps in 2021 and then tumbled by -3747200bps in 2025.
  • Ocular Therapeutix's Net Margin (Quarter) stood at 160.25% in 2021, then grew by 8bps to 147.67% in 2022, then dropped by -4bps to 153.65% in 2023, then crashed by -87bps to 286.92% in 2024, then tumbled by -72bps to 492.45% in 2025.
  • Its Net Margin was 492.45% in Q4 2025, compared to 467.35% in Q3 2025 and 499.31% in Q2 2025.